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 Abstract: Due to their chemical stability, high biocompatibility, excellent structural, optical, magnetic and 
catalytic properties, gold nanoparticles (AuNPs) have been widely used as therapeutics, delivery agents and 
transfection vectors. Since successful therapy for curing cancer, and other genetic diseases, requires the 
transport of DNA into the cell by delivery vehicles, the effective complexation of the DNA is a subject of great 
interest. In this sense, increasing concerns have been raised in regards to the thermodynamics and kinetics of 
non-covalent interactions of AuNPs with DNA. Although insights have been gained into the effects of AuNPs 
on DNA systems, there is still much ground to be covered, particularly in respect to our knowledge of the 
binding modes, conformational changes, the salt effects and the aggregation properties of these systems. This 
review highlights recent progress in the study of the interactive effects of AuNPs with DNA and the factors that 
influence the kinetics and thermodynamic of this interaction. 
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Introduction  
 
Damaging the replication machinery of DNA, either by 
covalent or non-covalent binding, is how normal anticancer 
drugs exhibit their antitumoral properties. Intercalation and 
groove fitting are the major modes of non-covalent 
interaction (NCI).1,2  NCI, those that occur between chemical 
species (molecules, ions, etc.), do not involve the formation 
of a covalent bond between the interacting species and play a 
key role in different fields of chemistry and biology, such as 
antigen/antibody interaction, the processes of solar energy 
conversion, environmental chemistry, self-aggregation 
phenomena, etc. Specifically, the recognition of proteins’ 
surfaces provides an attractive tool to regulate protein-protein 
interactions and enzymatic activities. Recently, research has 
been directed to the use of nanoparticles (NPs) as receptors 
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that bind to the protein’s surface through multivalent 
interactions. The binding affinity and stability of NPs can be 
adjusted by 1) the surface’s composition of the nanoparticle 
and functionality, and 2) varying buffer ionic strength. On the 
other hand, the size of nanoparticles is comparable to that of 
biomacromolecules, providing an efficient scaffold for 
binding biomacromolecules. Positively charged nanoparticles 
can be associated with DNA molecules to give very stable 
complexes, resulting in the disruption of DNA transcription. 
Furthermore, complex formation can also be exploited to 
protect DNA from enzymatic digestion, and positively 
charged nanoparticles can act as vectors to transfer DNA into 
cells.3 Studies concerning non-covalent interactions between 
nanoparticles and biopolymers are very few and have only 
been conducted recently. Published studies concerning 
nanoparticle-biopolymer interactions involving DNA and 
lysozyme 4, cytochrome C5 or albumin6 as model proteins, 
are very recent compared with studies concerning other types 
of substrate/receptor complexes. The importance of studying 
NCI is completely understood considering the so-called 
conformational diseases, like Alzheimer's disease, where β-
amyloid peptide undergoes a conformational change that 
leads to self-aggregation, giving rise to toxic species. Rotello 
et al. have described how highly charged nanoparticle-based 
hosts could serve as refolding agents by interacting with 
charged residues on denatured proteins, facilitating refolding 
and preventing aggregation.7 This review focuses on different 
aspects of NCI nanoparticles/biopolymers and how negative 
results could be a challenge to new avenues of insight. 
 
2. Nanomaterials and biomolecule interactions 
 
A large number of applications in the field of nanotechnology 
research are directly related to the binding of metal 
nanoparticles to sugars8, proteins9, dendrimers10, 
surfactants11, small ligands12 or DNA.13 Nanoparticles have 
been used for the construction of new materials, development 
of bioassays and as multivalent systems to study the 
interactions of different substrates/ligands. Especially 
interesting is the development of so-called 
glyconanoparticles for the study of interactions between 
carbohydrates. Of these, gold nanoparticles are the most 
stable metal nanoparticles with excellent biocompatibility 
and with promising applications, particularly due to their 
structural, electronic, optical, magnetic and catalytic 
properties.14 These interesting properties are having a 
significant impact in many areas of science, particularly in 
materials science and molecular biotechnology.15-17 Faced 
with metal or semiconductor particles, the properties of 
nanoparticles, in general, are characterized not only by those 
related to the metal cluster which constitutes the core of the 
structure, but also by the organic molecules on their surface, 
whose principal function is to confer stability to the structure 
and prevent the formation of metallic clusters. More 
specifically, NPs with alkanethiolates as protective agents, 
have received considerable attention because they confer 
certain advantages over other agents system: high stability, 
solubility in water, suspensibility in different solvents, simple 
characterization by standard analytical techniques such as 
NMR, UV-Vis and TEM18 and a flexible and versatile 
functionalization. Moreover, alkanethiolate gold 
nanoparticles are stable in physiological conditions; they are 
bioinert and provide non-toxic carriers for drug and gene 
delivery applications.18 During the last few decades, 
researchers have focused on the development of systems of 
nanoparticles covalently bonded to DNA.19 Some 
applications are related to the diagnosis and treatment of 
diseases20, detection of pathogens21, DNA biosensing22, 
probes and drug transport23 and fabrication of biosensors.24-26 
Most of these studies have been done with small DNA 
molecules and oligonucleotides. However, studies of non-
covalent interaction DNA/nanoparticle27, and more 
particularly with long chains of DNA, are relatively scarce in 
scientific literature.27a,28  
Nanomaterials with high levels of porosity are suitable to 
achieve a more controlled application of drugs. In gene 
therapy, the success depends on developing safe and effective 
gene vectors. Non-viral vectors, nanoparticles and lipid-DNA 
polymer complexes have been proposed as alternatives to 
viruses for introducing specific genes to cells.29  
Nanostructures are often unstable because of the small size of 
their constituents and their high chemical activity. Therefore, 
a major challenge is to increase the thermal stability and 
structural chemistry of these materials. 
Recently, sensors consisting of metal nanoparticles 
functionalized with DNA have appeared in the literature. It 
has been shown that these particles show affinities to the 
ligands that are, at least, two orders of magnitude greater than 
other conventional sensors.30 This has been attributed to the 
high density (packing) of the DNA on the nanoparticle’s 
surface, which provides multiple binding sites for the ligand 
(multivalency effect). However, affinity does not increase 
proportionally to packing, as it is necessary that a particular 
level of packaging is needed for optimizing ligand 
detection.31 The optimization of these interactions play an 
important role because of the possibility of synthesizing 
nanoparticles coated with amphiphilic or similar substances, 
which are able to act as vectors for gene transport and are 
much safer than the usual viral vectors, with the advantage of 
not causing immunological responses.32 It is known that the 
complex DNA vector must fulfill two main requirements: a) 
be relatively small and b) remain stable in the bloodstream. 
   Inhibition of DNA hybridization by metal nanoparticles has 
been studied.33 In these studies, small oligonucleotides are 
used and the non-specificity of the interaction is discussed 
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using melting techniques, UV-visible and transmission 
electron microscopy. DNA melting point analysis showed 
that the oligonucleotides adsorb strongly and nonspecifically 
on small metal nanoparticles, inhibiting the hybridization of 
complementary DNA sequences in common buffered 
solutions.  
Indeed, studies related to the nanoparticle-nucleic acid 
interactions focus mostly on the primary objective of a) the 
construction of biosensors, b) the synthesis of efficient 
vectors for the so-called photodynamic therapy (PDT)34 and 
c) obtaining inorganic nanoparticles as carriers of nucleic 
acids to cells.35 In this regard, there are studies related to the 
use of gold nanoparticles functionalized with short 
oligonucleotide DNA sequences "linkers"-O-(CH2)-SH in 
the extreme 5 'end of DNA (authors used only 24 
nucleotides).36 Other studies are concerned with the 
adsorption of single–stranded oligonucleotides on gold 
nanoparticles stabilized with sodium citrate. It appears that 
the displacement of citrate ions that stabilize the gold 
nanoparticles depends on the DNA sequence.37  
Gold nanoparticles “mix and read” sensors, together with 
sequence-specific oligonucleotides, have been used for the 
detection and recognition of mercury ions through changes 
from red to blue experienced by the electronic absorption 
band characteristic of gold nanoparticles (surface plasmon 
resonance).38 The synthesis of highly fluorescent gold 
nanoparticles to sense Hg have also been reported. These 
nanoparticles consist of alkanethiols and can be modified 
depending on the alkanethiol chain.39 The method is based on 
aggregation-induced quenching of the fluorescence of 11-
mercaptoundecanoic acid (11-MUA) protected AuNPs (11-
MUA-AuNPs; (2.0 ±_0.1) nm) in the presence of 2,6-
pyridinedicarboxylic acid (PDCA). This work provided the 
first example of a system for sensing Hg (II) ions based on 
fluorescence quenching through Hg (II)-induced aggregation 
of AuNPs. 
3. Thermodynamic and kinetic DNA-nanoparticle 
interaction 
 
It is well known that within the nucleus of eukaryotic cells, 
and more specifically within the chromatin, DNA is 
packaged and tightly bound to proteins. Chromatin is a 
complex of DNA and proteins, whose protein component is 
designated along with the name of histones (H1, H2A, H2B, 
H3 and H4). They contain many residues of arginine and 
lysine, which gives them a positive charge, its structure being 
quite similar in all organisms with a size of 7 nm.40 The 
positive charge of the histones, allows rapid bonding to DNA 
through the negatively charged phosphate groups. A key 
feature is that the chromatin structure also allows the orderly 
packaging of DNA molecules, therefore also allowing 
important processes to be carried out, such as the expression 
of genetic information and DNA replication. This is why the 
study of these structures is of such high importance. 
However, the precise structure of the chromatin fibre in the 
cell is not known in detail, and there is still some debate over 
this. In this regard, the DNA-nanoparticle system may be a 
good model to simulate the interactions occurring between 
proteins and DNA on histones. Complexes of DNA with 
oppositely charged particles in-vitro seem to be promising as 
model systems to reveal fundamental mechanisms of the 
natural packing of DNA by histone octamers. Accordingly, in 
recent decades research on the microscopic structure of 
different complexes composed of DNA molecules of great 
length and different complexing agents has been of particular 
interest. 27a, 28, 41 Some of these studies have clarified that the 
mode of interaction between semi-flexible long DNA 
molecules (ssDNA or dsDNA) and nanoparticles, is closely 
correlated with the conformation of DNA, the chain rigidity 
and the size of the nanosphere.27a, 28 Specifically, structural 
studies of systems consisting of well-defined monodisperse 
cationic nanoparticles (NP) (with various sizes ranging from 
10 to 100 nm) and single-chain bacteriophage T4 DNA (57 
µm contour length, 166 000 base pairs) have suggested the 
existence of different types of complexes and binding modes, 
depending on the size of the nanoparticle and the length of 
the DNA chain. These include: adsorption of DNA on the 
surface of the nanoparticle ("adsorption"), wrapping of DNA 
around the nanoparticle ("wrapping") and association of 
nanoparticles on the DNA strand ("collection")27a  (Figure 1). 
 
 
Figure 1. Different types of complexes and binding modes. 
Adapted from original picture of ref (27a). 
TEM observation allows the determination and 
characterization of the type of complex by direct observation 
of the number of nanoparticles per DNA chain. Zinchenko et 
al. determined the different types of DNA complexes [T4 
(166,000 bp)] with gold nanoparticles under conditions of 
complete compaction of the biopolymer through this 
technique.27 They studied compaction of single-stranded 
DNA by histone-inspired nanoparticles and found that the 
DNA compaction by nanoparticles is stepwise and 
progressive at the single-chain level. Thus, they distinguished 
between XL nanoparticles (from 5 to 8 nanoparticles per 
Adsorption Wrapping Collection 
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DNA chain), L nanoparticles (between 40 and 50 NPs for 
DNA strand), M nanoparticles (between 600 and 1200 NPs 
per chain) and S nanoparticles, containing more than 5000 
nanoparticles per chain. Nanoparticles of large size, XL and 
L, were found to interact with DNA by the so-called 
adsorption mechanism. This type of complexation is 
characterized by the existence of a large amount of DNA 
adsorbed on the nanoparticle and a small number of particles 
per chain of complexed DNA. Intermediate-sized 
nanoparticles in relation to the length of the DNA chain, type 
M, have a wrapping mechanism as their characteristic mode 
of interaction, in which the rigidity of the polymer chain 
becomes significantly important and the complexation is 
achieved by one or more turns of the DNA strand around the 
nanospheres. Indeed, the ability of DNA to wrap 
nanoparticles is more efficient for larger particles. Finally, in 
the extreme case of small nanoparticles, type S, the 
mechanism of interaction is a simple partnership in which 
small nanoparticles are adsorbed on the surface of DNA. In 
this case, the number of nanoparticles required to saturate a 
long chain of the biopolymer, such as the T4-type genomic 
DNA, is extremely large. Whatever type of partnership 
arrangement in the various systems involved 
DNA/nanoparticles, the binding of this particular type of 
ligands to DNA causes compaction of the biomolecule. The 
association of nanoparticles to DNA causes a reversible 
conformational change in the structure of DNA to more 
compact and condensed forms, as has been demonstrated by 
using different structural techniques, such as circular 
dichroism 27a, 27b, 42, TEM 27a, 27b, 28, AFM42-44 or fluorescence 
microscopy.28 In relation to the degree of compaction of 
DNA in the presence of nanoparticles, the saline effect has 
also been studied. The ability of DNA to wrap nanoparticles, 
similar to DNA-histone interaction, is optimal at 
physiological salt concentration. In general, regardless of the 
size of the nanoparticles, the addition of salt to AuNPs-DNA 
system decreases the nanoparticle concentration necessary to 
produce the compaction of DNA chains. This effect has been 
proven to be more pronounced for the interaction of small 
nanoparticles (S and M) with DNA.27a 
 
4. In-vivo DNA interactions: thermodynamic and kinetic 
aspects 
 
All processes in-vivo happen in the condensed DNA phase 
and all binding events should be treated accordingly. An 
adequate description of DNA-binding processes in crowded 
macromolecular environments is a real challenge which will 
require merging existing biochemical, electrostatic, 
thermodynamic and bioinformatic approaches. 
Macromolecular crowding is the basis for phase separation in 
the cytoplasm45 and condensation of DNA into the nucleus of 
bacterial cells.46,47 In-vitro, the compaction of the DNA 
molecule can be accomplished by adding agents, such as 
polyamines, multivalent metal cations, hydrophilic polymers, 
cationic polymers, cationic liposomes, cationic surfactants 
and, more recently, by nanoparticles. These changes can also 
be induced by varying the relative permittivity of the 
medium, the addition of cosolvents such as alcohols, and 
salts of highly charged ions. Alcohols have both electrostatic 
and structural effects on DNA, leading to three regimes of 
condensation. At the lowest alcohol concentrations, the B 
conformation is stable and condensation is relatively slow, 
allowing time for the packing adjustments necessary to form 
toroids. At intermediate alcohol concentrations, condensation 
is faster.  
The combined effects of solvents and ions as Co(NH3)63+ 
locally destabilize the double helix permitting DNA 
foldbacks that lead to rod like condensates. As the dielectric 
constant decreases from 80 to 65, rods become shorter and at 
the lowest dielectric constants, alcohol and Co(NH3)63+ 
produce A-DNA.48 The compactness is a property that is of 
significant importance in gene therapy and the efficiency of 
transfections.49 As non viral vectors, polycations may work 
well for efficient cell uptake and endosomal escape, because 
they form compact and smaller complexes with plasmid 
DNA and carry amine groups, which give a positive charge 
and buffering ability that allows safe escape from the 
endosome/lysosome.50 In fact, compaction of DNA, together 
with the reduction of its charge, facilitates the transport of 
nucleic acids through the cellular membrane.51 
The biological activity of nucleic acids not only depends on 
the thermodynamic properties of DNA-ligand complexes. It 
can be conditioned by the kinetics of the formation of these 
complexes. Binding kinetics may represent another important 
discriminating factor in structure-activity relationships. 
Therefore, it is of interest to analyze not only thermodynamic 
but also kinetic study of the interactions of DNA with 
nanoparticles. 
 
4.1 DNA-NP interaction thermodynamics 
 
One of the basic reasons why it is important to perform a 
thermodynamic study of DNA-nanoparticle systems is to 
determine the factors that govern the affinity and specificity 
of these nanosystems by the biopolymer (DNA). The 
equilibrium constants (association constant, K) and the 
corresponding Gibbs free energy can be determined 
following different procedures for both, to obtain 
experimental data which can be analysed. Over the years, 
equilibrium binding constants K have been calculated using a 
variety of methods developed by Scatchard, Mc. Ghee and 
von Hippel or Nordén.52 Spectroscopic methods are generally 
effective procedures for obtaining the parameter K. 
Interaction of nanoparticles with DNA induces changes in the 
spectroscopic properties of the nanoparticle (or DNA) and 
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these changes can be followed by the use of an adequate 
spectroscopic technique (UV-Vis, CD, NMR, or 
fluorescence). Given the multitude of ways by which a 
nanoparticle can bind to DNA, multifunctional nanoparticles 
are designed to determine the contribution of different kinds 
of interactions to the binding. Accordingly, for each DNA/ 
nanoparticle system, a global effect is exerted in conjunction 
with both the metal cluster and the capping agent of the 
nanocluster. Specifically, capping agents contribute to 
different abilities of the coordinated group, leading to 
intercalation, hydrogen bonding, and electrostatic 
interaction.53, 54  
Indeed, the interaction of nanoparticles with biomolecules 
and microorganisms is an expanding field of research. Within 
this field, an area that has been largely unexplored is the 
interaction of metal nanoparticles with viruses.55 Besides, 
each diagnostic/therapeutic technique requires a different 
chemical or physical property of the particle involved, which 
depends on the specific function played by the NPs in that 
therapy. An external interacting agent can be used to activate 
the particle function (for example, through magnetic field, 
light, radiation, etc). In this sense, the requirements for NPs 
as biomedical agents span a broad range of novel materials, 
synthesis strategies and research fields.56  
Reversible hybridization of complementary DNA is 
fundamental to biological processes, such as replication and 
transcription. The hybridization kinetics experiment is 
executed with the use of a single-stranded DNA (ss-DNA) 
probe attached to a substrate to detect the target DNA in 
solution. The processes of hybridization/dehybridization of 
DNA and the aggregation/dissociation of the 
DNA/nanoparticle systems, are influenced by the size of the 
nanoparticle. However, other variables must be taken into 
account, such as the surface density of oligonucleotides, the 
dielectric constant of the medium, the salt concentration and 
the concentration of DNA. For this reason, in order to 
consider a complete thermodynamic model to explain these 
processes the dependence of the equilibrium interaction 
constant of these systems according to these variables must 
be studied. During the last few decades, several authors have 
directed their efforts towards the preparation of nanoparticles 
covalently bonded to DNA.57 The dissociation of the double 
strand, in systems containing aggregates of DNA 
molecules/nanoparticles, is cooperative. One of the most 
important theoretical models for evaluating the relative 
importance of various factors in the processes of aggregation 
of nanoparticles covalently linked to oligonucleotides has 
been developed by Jin Rongchao et al58 (Figure 2). They 
observed that as the dissociation of the DNA strands take 
place there is a decrease in the local concentration of salt in 
the aggregate. This gradual decrease in salt concentration 
implies that there is a decrease in local dielectric constant, 
causing a decrease in the melting temperature of the system. 
These facts were key to suppose a cooperative mechanism for 
dissociation/aggregation of gold nanoparticles, in which the 
first step of the mechanism is associated with a higher 
melting temperature, and hence a smaller equilibrium 
constant for the next step and so on. Recently, also through 
cooperative melting properties, J. S. Lee et al have found that 
salt concentration-induced dehybridization of DNA-gold 
nanoparticle conjugate assemblies for diagnostic 
applications. 59 
 
 
 
 
 
 
Figure 2. Cooperative mechanism for dissociation/ 
aggregation of gold nanoparticles. Adapted from reference 
(58).  
From a quantitative point of view, Rongchao et al. found that 
the influence of the core size of gold nanoparticles 
functionalized with oligonucleotides (13, 31 and 50 nm) 
results in values of free enthalpy of 275.8, 473.8 and 706.8 
kcal.mol-1 respectively.58 Therefore, the melting curves are 
more pronounced or vertical as the size of the nanoparticle 
increases. This increase in enthalpy of dissociation with the 
nanoparticle size implies that the number of connections 
through the oligonucleotides between each pair of 
nanoparticles proportionally increases with size. In the field 
of nanoparticles as biosensors, fluorescent nanoparticles that 
can be attached to biological molecules are being developed 
for use in microscopic sensor devices. Within the 
DNA/nanoparticle systems for biosensors, fabrication is of 
interest to analyze and compare the thermodynamic 
properties of association of these systems with systems using 
conventional fluorescent probes. Mirkin et al60 have 
compared the interaction between the oligonucleotide chains 
of both type systems through the study of the melting curves, 
depending on the concentration of reagents. In this work, 
only the association/dissociation of nanoparticles 
(functionalized with oligonucleotides) with complementary 
oligonucleotides is considered, regardless of the possible 
aggregation of the system. From a linear representation of 
1/Tm against lnCT (CT is the total concentration of 
nanoparticle and fluorophore, or quencher together with 
fluorophore) they can determinate the equilibrium parameters 
of both systems (ΔH0, ΔS0, K) through the Breslauer 
equation.61  
Although different factors determine the interaction between 
inorganic nanoparticles and DNA, this one is mostly driven 
by the average size of the first. Recently, the interaction of 9 
T>Tm
T<Tm
T>Tm
T<Tm
.....
T>Tm
T<Tm
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nm monohydroxy-(1-mercaptoundec-11-yl)-tetraethylene-
glycol-capped neutral Au nanoparticles of about 2.8 nm of 
core diameter with shortened calf thymus DNA (ct-DNA, 
800 bp) has been investigated by spectrophotometric and 
spectrofluorimetric titrations.62 Negative results were 
obtained by the authors. Due to the nature and length of the 
capping agent, no significant nanoparticle spectral variation 
upon DNA addition could be observed by Secco et al. in 
order to analyse the binding constant DNA/AuNPs 
quantitatively.62 In this sense, and starting from these 
negative results, Grueso et al. observed that, although 
absorption spectra were not valid to measure the equilibrium 
binding constant DNA/AuNPs, the circular dichroism (CD) 
technique provides an alternative path to evaluate the 
interaction of neutral tiopronin gold nanoparticles 
(Au@tiopronin) with long DNA chains.42 The binding of ct-
DNA with gold nanoparticles capped with N-(2-
mercaptopropionyl)glycine was investigated through AFM, 
absorption, intrinsic circular dichroism, viscosity 
measurements, melting analysis and steady state-
fluorescence. The results indicate that neutral Au@tiopronin 
bind tightly to ct-DNA. This is a clear example were negative 
results provide a valuable resource for researchers. 
 
4.2 DNA-NP interaction kinetics 
 
Kinetic studies of hybridization/de-hybridization processes 
involving nanoparticles covalently bound to oligonucleotides 
are less frequent than thermodynamic studies. Two processes 
are critical in the cluster formation rate: a) the annealing, 
characterized by a constant k1 and b) the aggregation growth 
rate from DNA already hybridized in the nanoparticle, 
characterized by a constant k2. The size of the 
oligonucleotide controls the speed of both processes.63 
Recent studies have allowed a first estimation of the rate 
constants corresponding to the aggregation of these systems, 
using Avrami's law for the growth of molecular aggregates 
by nucleation.64 Another interesting study reports on the 
kinetics of hybridization events. The scope of this work is to 
apply the plasmonic heating effect to the AuNPs/DNA 
system in an optical trap, so allowing the investigation of the 
kinetics of nanoparticle oxidation and growth.65 Although 
insights have been gained into the kinetics of hybridization of 
AuNPs/DNA system, all of these studies correspond to 
AuNPs functionalized with DNA. Kinetic studies of non-
covalent interactions (NCI) between nanosystems and free 
DNA molecules are extremely rare. Regardless of the 
complexation mode, the binding of NPs to DNA causes a 
reversible conformational compacted change in the DNA 
structure. However, a comprehensive mechanism to describe 
the kinetic behaviour of DNA-based nanosystems is still 
required.  
    As these systems allow for more sophisticated detection 
and increasingly complex bottom-up construction, a protocol 
for the regulation of the nanoparticle–DNA assembly kinetics  
would be beneficial. Unfortunately, nowadays kinetics and 
mechanistic studies of the non-covalent interaction of DNA 
with gold nanoparticles are scarce. Prado-Gotor et al. has 
recently studied the interaction of gold nanoparticles capped 
with N-(2-mercaptopropionyl) glycine (Au@tiopronin) with 
double stranded DNA.42 This study was carried out in water 
and brine (NaCl) solutions and revealed the presence of three 
kinetic steps with biexponential kinetic curves (a typical 
kinetic experiment is given in Figure 3). 
 
 
 
 
 
 
 
Figure 3. Au@tiopronin nanoparticle and plot of ellipticity, 
θ, vs time, t, in a typical kinetic experiment between DNA 
and Au@tiopronin. The curve is the best fit to the 
experimental data. Adapted from reference (42). 
 
There is a dependence of the reciprocal fast and slow 
relaxation time curve on the DNA concentration. At high 
DNA concentrations both reciprocal relaxation times tend to 
plateau. Although different mechanisms are consistent with 
the kinetic results, the simplest ones involve a three-step 
series mechanism reaction scheme. The first step corresponds 
to a very fast process related to a diffusion controlled 
formation of an external precursor complex (DNA, AuNPs); 
the binding affinity between hydrophilic groups of the 
tiopronin and the DNA grooves involves a second step with 
the formation of a (DNA/AuNPs)I complex. Subsequently, a 
conformational change of the (DNA/AuNPs)I complex 
formed in the second step to a more compacted form 
(DNA/AuNPs)II corresponds to the third step. The values of 
the rate constants of each step decrease as NaCl 
concentration increases. The results were discussed in terms 
of solvation of the species and changes in the viscosity of the 
solution.42 Information about the kinetics of compaction 
processes is fundamental because the mechanism of these 
processes is poorly understood. The dynamics of higher-
order chromatin compaction play a crucial role in 
transcription and other biological processes inherent to DNA. 
Kinetic information is particularly necessary in relation to 
gene transport because the release rate of DNA from vectors 
is one of the many parameters that control this process.66 
t(s)
0,2 0,4 0,6 0,8
θ (
m
ill
id
eg
re
e)
0
100
200
300
S
S
SSS
S
SS
S
SS
SS
S
S
S
Au
6
All Res. J.Chem, 2013, 4, 1-9 
	   	  
Indeed, DNA release into the tissue can occur rapidly, as in 
bolus delivery, or extend over days to months. 67-69 
5. Negative results of Nanoparticles as DNA sensors 
 
Kyungnam el al70 studied the effect of adding salt to DNA 
and gold nanoparticles coated with citrate (negatively 
charged). They found that the addition of DNA and salt to the 
system produced a change in the electrostatic properties of 
the system that favors the aggregation of nanoparticles. The 
aggregation of nanoparticles can be easily detected by UV-
Vis techniques due to the change of colour that the 
dissolution suffers as the aggregation of nanoparticles occurs. 
This colour change results in a shift in the UV-vis absorption 
spectrum of the system to longer wavelengths (red shift). 
This property has allowed the use of these systems as 
biosensors for detecting DNA.71 Until salt concentrations 
corresponding to 0.015 M in NaCl, negligible changes were 
observed in the UV-vis spectrum, ruling out the aggregation 
of these nanoparticles under these concentrations.70 The 
addition of salt implies the destabilization of the gold 
nanoparticles due to shielding of electrostatic repulsion 
between them, suggesting that the control of salt 
concentration of the medium is somehow regulating the 
electrostatic repulsion between gold nanoparticles, inducing a 
selective aggregation of them. 
To date, when using gold nanoparticles as colorimetric 
sensors, it is only possible to detect the presence of single-
stranded DNA in a biological fluid. The results are negative 
when detecting double-stranded DNA (dsDNA) using 
anionic nanoparticles protected by citrate ions. The reason is 
that compared to dsDNA, single stranded DNA (ssDNA) has 
different propensities to adsorb onto unmodified gold 
nanoparticles due to their dissimilar electrostatic 
interactions.72 In this sense, ssDNA is known to be able to 
adsorb on AuNPs and to stabilize colloidal suspensions in 
high salt concentration.73 ssDNA can uncoil to expose its 
bases, but duplex DNA (dsDNA) is characterized by its 
stable DNA-DNA double-helix geometry. For this reason 
dsDNA always isolates the nucleotides presenting the 
negatively charged phosphate backbone, showing little 
affinity to negatively charged AuNPs. Thus, dsDNA cannot 
protect AuNPs from salt-induced aggregation, as compared 
to ssDNA. Normally, this process is detectable as a color 
change of the colloidal solution and red shift of the surface 
plasmon band. This characteristic behaviour allowed to 
develop colorimetric assay for ssDNA detection based on the 
aggregation of unmodified metallic nanoparticles.74 
Citrate coated gold nanoclusters75 present a negative charge 
of about –30 mV in water, enough to keep the particles 
dispersed and with a stable particle size. The repulsion 
between these two negative entities (citrate NPs and the 
charged phosphate backbone of dsDNA) is the reason why 
dsDNA do not adsorb. One of the characteristics of ssDNA is 
its flexibility. Thanks to that, the ssDNA can partially uncoil 
its bases, so that they can be exposed to the gold 
nanoparticles. Under these conditions, the negative charge on 
the backbone is sufficiently distant of the nanaoparticles. 
This fact together with the attractive van der Waals forces 
between the bases of the biopolymer and the gold 
nanoparticle (bare particles) is sufficient to bond ssDNA to 
the gold. This mechanism is not operative with dsDNA 
because the duplex structure does not permit the uncoiling 
needed to expose the bases. This system therefore allows the 
determination of ssDNA in a solution, but not dsDNA. 
Meanwhile color changes of the solution, triggered by the 
addition of additive such as NaCl, are retarded if the solution 
contains ssDNA, color alteration of colloidal gold solution is 
not affected by dsDNA oligonucleotides.76 This negative 
result is a challenge in the current field for developing new 
biosensors based on non-functionalized nanoparticles. 
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